The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Dendritic cell-based immunotherapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Antigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Corrales, L., Glickman, L. H., McWhirter, S. M., Kanne, D. B., Sivick, K. E., Katibah, G. E., Woo, S.-R., Lemmens, E., Banda, T., Leong, J. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.031 · Cited by 1,560
Pathways of Antigen Processing
Blum, J. S., Wearsch, P. A., & Cresswell, P. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095910 · Cited by 1,547
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Signalling through C-type lectin receptors: shaping immune responses
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2009) · Nature Reviews Immunology · doi:10.1038/nri2569 · Cited by 1,379
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,365
Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., & Bhardwaj, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.233 · Cited by 1,359
Self-citationA dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Carreno, B. M., Magrini, V., Becker-Hapak, M., Kaabinejadian, S., Hundal, J., Petti, A. A., Ly, A., Lie, W.-R., Hildebrand, W. H., Mardis, E. R., et al. (2015) · Science · doi:10.1126/science.aaa3828 · Cited by 1,285
Decisions About Dendritic Cells: Past, Present, and Future
Steinman, R. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100311-102839 · Cited by 1,274
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,201
Self-citationDendritic cells in a mature age
Reis e Sousa, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1845 · Cited by 1,195
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells
Langenkamp, A., Messi, M., Lanzavecchia, A., & Sallusto, F. (2000) · Nature Immunology · doi:10.1038/79758 · Cited by 1,143
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
Small, E. J., Schellhammer, P. F., Higano, C. S., Redfern, C. H., Nemunaitis, J. J., Valone, F. H., Verjee, S. S., Jones, L. A., & Hershberg, R. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5252 · Cited by 1,108
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Cancer immunoediting from immune surveillance to immune escape
Kim, R., Emi, M., & Tanabe, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02587.x · Cited by 1,074
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
Tang, Q., & Bluestone, J. A. (2008) · Nature Immunology · doi:10.1038/ni1572 · Cited by 1,031
Roberts, E. W., Broz, M. L., Binnewies, M., Headley, M. B., Nelson, A. E., Wolf, D. M., Kaisho, T., Bogunovic, D., Bhardwaj, N., & Krummel, M. F. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.003 · Cited by 1,026
Self-citationMunn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
Sharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
Sancho, D., Joffre, O. P., Keller, A. M., Rogers, N. C., Martínez, D., Hernanz-Falcón, P., Rosewell, I., & Sousa, C. R. E. (2009) · Nature · doi:10.1038/nature07750 · Cited by 750
Haniffa, M., Shin, A., Bigley, V., McGovern, N., Teo, P., See, P., Wasan, P. S., Wang, X.-N., Malinarich, F., Malleret, B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.012 · Cited by 724
Linnemann, C., van Buuren, M. M., Bies, L., Verdegaal, E. M. E., Schotte, R., Calis, J. J. A., Behjati, S., Velds, A., Hilkmann, H., Atmioui, D. E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3773 · Cited by 679
Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., & Rivoltini, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5829 · Cited by 647
Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells
Small, E. J., Fratesi, P., Reese, D. M., Strang, G., Laus, R., Peshwa, M. V., & Valone, F. H. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3894 · Cited by 625
Jaensson, E., Uronen-Hansson, H., Pabst, O., Eksteen, B., Tian, J., Coombes, J. L., Berg, P.-L., Davidsson, T., Powrie, F., Johansson-Lindbom, B., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080414 · Cited by 614
Le, D. T., Wang-Gillam, A., Picozzi, V., Greten, T. F., Crocenzi, T., Springett, G., Morse, M., Zeh, H., Cohen, D., Fine, R. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.4244 · Cited by 611
Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Brown, S. D., Warren, R. L., Gibb, E. A., Martin, S. D., Spinelli, J. J., Nelson, B. H., & Holt, R. A. (2014) · Genome Research · doi:10.1101/gr.165985.113 · Cited by 594
Schlitzer, A., Sivakamasundari, V, Chen, J., Sumatoh, H. R. B., Schreuder, J., Lum, J., Malleret, B., Zhang, S., Larbi, A., Zolezzi, F., et al. (2015) · Nature Immunology · doi:10.1038/ni.3200 · Cited by 574
Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T. E., Mintz, A. H., Engh, J. A., Bartlett, D. L., Brown, C. K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7744 · Cited by 567
Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214364 · Cited by 562
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Lutz, E. R., Wu, A. A., Bigelow, E., Sharma, R., Mo, G., Soares, K., Solt, S., Dorman, A., Wamwea, A., Yager, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0027 · Cited by 550
Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs
Fujii, S.-I., Shimizu, K., Kronenberg, M., & Steinman, R. M. (2002) · Nature Immunology · doi:10.1038/ni827 · Cited by 544
Origin and development of dendritic cells
Liu, K., & Nussenzweig, M. C. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00879.x · Cited by 543
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Mitchell, D. A., Batich, K. A., Gunn, M. D., Huang, M.-N., Sanchez-Perez, L., Nair, S. K., Congdon, K. L., Reap, E. A., Archer, G. E., Desjardins, A., et al. (2015) · Nature · doi:10.1038/nature14320 · Cited by 531
Scandella, E., Men, Y., Gillessen, S., Förster, R., & Groettrup, M. (2002) · Blood · doi:10.1182/blood-2001-11-0017 · Cited by 500
Collin, M., McGovern, N., & Haniffa, M. (2013) · Immunology · doi:10.1111/imm.12117 · Cited by 500
Transcriptional Control of Dendritic Cell Development
Murphy, T. L., Grajales-Reyes, G. E., Wu, X., Tussiwand, R., Briseño, C. G., Iwata, A., Kretzer, N. M., Durai, V., & Murphy, K. M. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120204 · Cited by 489
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., Advani, R. H., Kim, Y. H., Hoppe, R. T., Knox, S. J., Shin, L. K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9793 · Cited by 487
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., & Roncarolo, M. G. (2005) · Blood · doi:10.1182/blood-2004-03-1211 · Cited by 483
(2003) · PubMed · Cited by 477
α-Type-1 Polarized Dendritic Cells
Mailliard, R. B., Wankowicz-Kalinska, A., Cai, Q., Wesa, A., Hilkens, C. M., Kapsenberg, M. L., Kirkwood, J. M., Storkus, W. J., & Kalinski, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1261 · Cited by 470
Dhodapkar, M. V., Steinman, R. M., Sapp, M., Desai, H., Fossella, C., Krasovsky, J., Donahoe, S. M., Dunbar, P. R., Cerundolo, V., Nixon, D. F., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6909 · Cited by 468
Self-citationWinograd, R., Byrne, K. T., Evans, R. A., Odorizzi, P. M., Meyer, A. R. L., Bajor, D. L., Clendenin, C., Stanger, B. Z., Furth, E. E., Wherry, E. J., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0215 · Cited by 459
Beatty, G. L., Torigian, D. A., Chiorean, E. G., Saboury, B., Brothers, A., Alavi, A., Troxel, A. B., Sun, W., Teitelbaum, U. R., Vonderheide, R. H., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1320 · Cited by 456
The role of CD40 and CD154/CD40L in dendritic cells
Ma, D. Y., & Clark, E. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.010 · Cited by 446
Visualization of immediate immune responses to pioneer metastatic cells in the lung
Headley, M. B., Bins, A., Nip, A., Roberts, E. W., Looney, M. R., Gerard, A., & Krummel, M. F. (2016) · Nature · doi:10.1038/nature16985 · Cited by 439
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.
Nowak, A. K., Robinson, B. W. S., & Lake, R. (2003) · PubMed · Cited by 421
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
McKenna, K., Beignon, A.-S., & Bhardwaj, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.17-27.2005 · Cited by 394
Self-citationFirst oncolytic virus approved for melanoma immunotherapy
Pol, J., Kroemer, G., & Galluzzi, L. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1115641 · Cited by 392
Welters, M. J. P., Kenter, G. G., Piersma, S. J., Vloon, A. P. G., Löwik, M. J. G., Berends-van der Meer, D. M. A., Drijfhout, J. W., Valentijn, A. R. P. M., Wafelman, A. R., Oostendorp, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1880 · Cited by 373
Dhodapkar, M. V., & Steinman, R. M. (2002) · Blood · doi:10.1182/blood.v100.1.174 · Cited by 363
Tel, J., Aarntzen, E. H. J. G., Baba, T., Schreibelt, G., Schulte, B. M., Benitez-Ribas, D., Boerman, O. C., Croockewit, S., Oyen, W. J. G., van Rossum, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2583 · Cited by 353
Hartmann, E., Wollenberg, B., Rothenfußer, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., & Hartmann, G. (2003) · PubMed · Cited by 332
Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
Pinzon‐Charry, A., Maxwell, T., & López, J. A. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01371.x · Cited by 328
de Vries, I. J. M., Lesterhuis, W. J., Scharenborg, N. M., Engelen, L. P. H., Ruiter, D. J., Gerritsen, M. P., Croockewit, S., Britten, C. M., Torensma, R., Adema, G. J., et al. (2003) · PubMed · Cited by 327
Nair-Gupta, P., Baccarini, A., Tung, N., Seyffer, F., Florey, O., Huang, Y., Banerjee, M., Overholtzer, M., Roche, P. A., Tampé, R., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.054 · Cited by 325
Huysamen, C., Willment, J. A., Dennehy, K. M., & Brown, G. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709923200 · Cited by 318
Cancer immunotherapy with mRNA‐transfected dendritic cells
Gilboa, E., & Vieweg, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00139.x · Cited by 316
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Löwik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Drijfhout, J. W., Wafelman, A. R., Oostendorp, J., Fleuren, G. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1881 · Cited by 315
Wilgenhof, S., Corthals, J., Heirman, C., van Baren, N., Lucas, S., Kvistborg, P., Thielemans, K., & Neyns, B. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4121 · Cited by 313
Specialized role of migratory dendritic cells in peripheral tolerance induction
Idoyaga, J., Fiorese, C., Zbytnuik, L., Lubkin, A., Miller, J., Malissen, B., Mucida, D., Merad, M., & Steinman, R. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65260 · Cited by 305
Inflammatory dendritic cells in mice and humans
Segura, E., & Amigorena, S. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.06.001 · Cited by 300
Gerner, M. Y., Torabi-Parizi, P., & Germain, R. N. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.024 · Cited by 299
Human tumor antigens for cancer vaccine development
Wang, R., & Rosenberg, S. A. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01331.x · Cited by 296
Idoyaga, J., Lubkin, A., Fiorese, C., Lahoud, M. H., Caminschi, I., Huang, Y., Rodriguez, A., Clausen, B. E., Park, C. G., Trumpfheller, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019547108 · Cited by 287
Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages
McGovern, N., Schlitzer, A., Gunawan, M., Jardine, L., Shin, A., Poyner, E., Green, K., Dickinson, R., Wang, X.-N., Low, D., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.006 · Cited by 281
Sæterdal, I., Bjørheim, J., Lislerud, K., Gjertsen, M. K., Bukholm, I. K., Olsen, O. C., Nesland, J. M., Eriksen, J. A., Møller, M., Lindblom, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231326898 · Cited by 273
Sabbatini, P., Tsuji, T., Ferran, L., Ritter, E., Sedrak, C., Tuballes, K., Jungbluth, A. A., Ritter, G., Aghajanian, C., Bell-McGuinn, K., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2189 · Cited by 272
Tacken, P. J., de Vries, I. J. M., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J. A., Torensma, R., Adema, G. J., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0318 · Cited by 272
Garg, A. D., Vandenberk, L., Koks, C., Verschuere, T., Boon, L., Van Gool, S. W., & Agostinis, P. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aae0105 · Cited by 270
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow
Lee, J., Breton, G., Oliveira, T. Y. K., Zhou, Y. J., Aljoufi, A., Puhr, S., Cameron, M. J., Sékaly, R.-P., Nussenzweig, M. C., & Liu, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141442 · Cited by 263
Sheikh, N. A., Petrylak, D., Kantoff, P. W., dela Rosa, C., Stewart, F. P., Kuan, L.-Y., Whitmore, J. B., Trager, J. B., Poehlein, C. H., Frohlich, M. W., et al. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1317-2 · Cited by 263
Munn, D. H., & Mellor, A. L. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.11.003 · Cited by 259
Somersan, S., Larsson, M., Fonteneau, J. F., Basu, S., Srivastava, P., & Bhardwaj, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4844 · Cited by 258
Self-citationDifferential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells
Penna, G., Vulcano, M., Sozzani, S., & Adorini, L. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00755-3 · Cited by 252
Schreibelt, G., Bol, K. F., Westdorp, H., Wimmers, F., Aarntzen, E. H. J. G., Duiveman-de Boer, T., van de Rakt, M. W. M. M., Scharenborg, N. M., de Boer, A. J., Pots, J. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2205 · Cited by 241
Cools, N., Ponsaerts, P., Van Tendeloo, V. F. I., & Berneman, Z. N. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307166 · Cited by 235
Palucka, A. K., Ueno, H., Connolly, J., Kerneis-Norvell, F., Blanck, J.-P., Johnston, D. A., Fay, J., & Banchereau, J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211309.90621.8b · Cited by 234
Sensing pathogens and danger signals by the inflammasome
Pedra, J. H., Cassel, S. L., & Sutterwala, F. S. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.006 · Cited by 233
Bijker, M. S., van den Eeden, S. J. F., Franken, K. L., Melief, C. J. M., van der Burg, S. H., & Offringa, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200737995 · Cited by 229
Rosenblatt, J., Vasir, B., Uhl, L., Blotta, S., MacNamara, C., Somaiya, P., Wu, Z., Joyce, R., Levine, J. D., Dombagoda, D., et al. (2011) · Blood · doi:10.1182/blood-2010-04-277137 · Cited by 228
Lahoud, M. H., Ahmet, F., Kitsoulis, S., Wan, S. S., Vremec, D., Lee, C.-N., Phipson, B., Shi, W., Smyth, G. K., Lew, A. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101176 · Cited by 227
Chiang, C. L.-L., Kandalaft, L. E., Tanyi, J., Hagemann, A. R., Motz, G. T., Svoronos, N., Montone, K., Mantia-Smaldone, G. M., Smith, L., Nisenbaum, H. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1185 · Cited by 218
Fong, L., Carroll, P., Weinberg, V., Chan, S., Lewis, J., Corman, J., Amling, C. L., Stephenson, R. A., Simko, J., Sheikh, N. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju268 · Cited by 215
Draube, A., Klein-González, N., Mattheus, S., Brillant, C., Hellmich, M., Engert, A., & von Bergwelt-Baildon, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018801 · Cited by 214
Lee, A. W., Truong, T., Bickham, K., Fonteneau, J.-F., Larsson, M., Da Silva, I., Somersan, S., Thomas, E. K., & Bhardwaj, N. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00382-1 · Cited by 207
Self-citationAmin, A., Dudek, A. Z., Logan, T. F., Lance, R. S., Holzbeierlein, J. M., Knox, J. J., Master, V. A., Pal, S. K., Miller, W. H., Karsh, L. I., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0055-3 · Cited by 205
Nair, S. K., Morse, M., Boczkowski, D., Ian Cumming, R., Vasovic, L., Gilboa, E., & Kim Lyerly, H. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00013 · Cited by 205
MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
Cobbold, M., De La Peña, H., Norris, A., Polefrone, J. M., Qian, J., English, A. M., Cummings, K. L., Penny, S., Turner, J. E., Cottine, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006061 · Cited by 204
Verdijk, P., Aarntzen, E. H. J. G., Lesterhuis, W. J., Boullart, A. C. I., Kok, E., van Rossum, M. M., Strijk, S., Eijckeler, F., Bonenkamp, J. J., Jacobs, J. F. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2729 · Cited by 204
Schnurr, M., Chen, Q., Shin, A., Chen, W., Toy, T., Jenderek, C., Green, S., Miloradovic, L., Drane, D., Davis, I. D., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3105 · Cited by 203
Circulating precursors of human CD1c+ and CD141+ dendritic cells
Breton, G., Lee, J., Zhou, Y. J., Schreiber, J. J., Keler, T., Puhr, S., Anandasabapathy, N., Schlesinger, S., Caskey, M., Liu, K., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141441 · Cited by 203
Cohn, L., Chatterjee, B., Esselborn, F., Smed-Sörensen, A., Nakamura, N., Chalouni, C., Lee, B.-C., Vandlen, R., Keler, T., Lauer, P., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121251 · Cited by 200
Salio, M., Cella, M., Vermi, W., Facchetti, F., Palmowski, M. J., Smith, C. L., Shepherd, D., Colonna, M., & Cerundolo, V. (2003) · European Journal of Immunology · doi:10.1002/eji.200323676 · Cited by 198
Lesterhuis, W. J., de Vries, I. J. M., Schreibelt, G., Lambeck, A. J. A., Aarntzen, E. H. J. G., Jacobs, J. F. M., Scharenborg, N. M., van de Rakt, M. W. M. M., de Boer, A. J., Croockewit, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1261 · Cited by 193
Gallo, P. M., & Gallucci, S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00138 · Cited by 190
Speetjens, F. M., Kuppen, P. J. K., Welters, M. J. P., Essahsah, F., Voet van den Brink, A. M. E. G., Lantrua, M. G. K., Valentijn, A. R. P. M., Oostendorp, J., Fathers, L. M., Nijman, H. W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2227 · Cited by 185
Viral vectors for dendritic cell-based immunotherapy
Jenne, L., Schuler, G., & Steinkasserer, A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01813-5 · Cited by 180
Schnurr, M. M., Galambos, P., Scholz, C., Then, F., Dauer, M., Endres, S., & Eigler, A. (2001) · PubMed · Cited by 179
Ratzinger, G., Baggers, J., de Cos, M. A., Yuan, J., Dao, T., Reagan, J. L., Münz, C., Heller, G., & Young, J. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2780 · Cited by 175
Tel, J., Schreibelt, G., Sittig, S. P., Mathan, T. S. M., Buschow, S. I., Cruz, L. J., Lambeck, A. J. A., Figdor, C. G., & de Vries, I. J. M. (2013) · Blood · doi:10.1182/blood-2012-06-435644 · Cited by 174
Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA
Koido, S., Kashiwaba, M., Chen, D., Gendler, S., Kufe, D., & Gong, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5713 · Cited by 174
Sharma, A., Koldovsky, U., Xu, S., Mick, R., Roses, R., Fitzpatrick, E., Weinstein, S., Nisenbaum, H., Levine, B. L., Fox, K., et al. (2012) · Cancer · doi:10.1002/cncr.26734 · Cited by 164
IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
Carreno, B. M., Becker-Hapak, M., Huang, A., Chan, M., Alyasiry, A., Lie, W.-R., Aft, R. L., Cornelius, L. A., Trinkaus, K. M., & Linette, G. P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68395 · Cited by 164
Dendritic cell‐targeted protein vaccines: a novel approach to induce T‐cell immunity
Trumpfheller, C., Longhi, M. P., Caskey, M., Idoyaga, J., Bozzacco, L., Keler, T., Schlesinger, S. J., & Steinman, R. M. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02496.x · Cited by 161
C-type lectins on dendritic cells: key modulators for the induction of immune responses
van Kooyk, Y. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361478 · Cited by 159
Boullart, A. C. I., Aarntzen, E. H. J. G., Verdijk, P., Jacobs, J. F. M., Schuurhuis, D. H., Benítez‐Ribas, D., Schreibelt, G., van de Rakt, M. W. M. M., Scharenborg, N. M., de Boer, A. J., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0489-2 · Cited by 155
Constantino, J., Gomes, C. M. F., Falcão, A. C., Cruz, M. T., & Neves, B. M. (2015) · Translational research · doi:10.1016/j.trsl.2015.07.008 · Cited by 154
Yewdall, A. W., Drutman, S. B., Jinwala, F., Bahjat, K. S., & Bhardwaj, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011144 · Cited by 154
Self-citationHe, Y., Zhang, J., Mi, Z., Robbins, P. D., & Falo, L. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3808 · Cited by 152
Heiser, A., Maurice, M. A., Yancey, D. R., Coleman, D., Dahm, P., & Vieweg, J. (2001) · PubMed · Cited by 149
Dendritic Cells Control B Cell Growth and Differentiation
Jégo, G., Pascual, V., Palucka, A. K., & Banchereau, J. (2004) · KARGER eBooks · doi:10.1159/000082101 · Cited by 148
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
Salcedo, M., Bercovici, N., Taylor, R. R., Vereecken, P., Massicard, S., Duriau, D., Vernel-Pauillac, F., Boyer, A., Baron‐Bodo, V., Mallard, E., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0078-6 · Cited by 145
Dyall, J., Latouche, J., Schnell, S., & Sadelain, M. (2001) · Blood · doi:10.1182/blood.v97.1.114 · Cited by 144
Leffers, N., Lambeck, A. J. A., Gooden, M. J. M., Hoogeboom, B. N., Wolf, R., Hamming, I. L. E., Hepkema, B. G., Willemse, P. H. B., Molmans, B. H. W., Hollema, H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24597 · Cited by 144
Chen, W., Antonenko, S. V., Sederstrom, J. M., Liang, X., Chan, A. S. H., Kanzler, H., Blom, B., Blazar, B. R., & Liu, Y. (2003) · Blood · doi:10.1182/blood-2003-09-3058 · Cited by 144
Colino, J., Shen, Y., & Snapper, C. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.20011432 · Cited by 142
Strobel, I., Berchtold, S., Götze, A., Schulze, U., Schuler, G., & Steinkasserer, A. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301326 · Cited by 138
Cheong, C., Choi, J.-H., Vitale, L. A., He, L.-Z., Trumpfheller, C., Bozzacco, L., Do, Y., Nchinda, G., Park, S., Dandamudi, D., et al. (2010) · Blood · doi:10.1182/blood-2010-06-288068 · Cited by 135
GuhaThakurta, D., Sheikh, N. A., Fan, L.-Q., Kandadi, H., Meagher, T. C., Hall, S. J., Kantoff, P. W., Higano, C. S., Small, E. J., Gardner, T. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2334 · Cited by 133
Role of Altered Expression of HLA Class I Molecules in Cancer Progression
Aptsiauri, N., Cabrera, T., Méndez, R., Garcia-Lor, A., Ruiz‐Cabello, F., & Garrido, F. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_13 · Cited by 132
Cross-Presentation in Mouse and Human Dendritic Cells
Segura, É., & Amigorena, S. (2015) · Advances in immunology · doi:10.1016/bs.ai.2015.03.002 · Cited by 132
Schroers, R., Sinha, I., Segall, H., Schmidt‐Wolf, I. G. H., Rooney, C. M., Brenner, M. K., Sutton, R. E., & Chen, S. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0027 · Cited by 131
Meixlsperger, S., Leung, C. S. K., Rämer, P. C., Pack, M., Vanoaica, L. D., Breton, G., Pascolo, S., Salazar, A. Μ., Dzionek, A., Schmitz, J., et al. (2013) · Blood · doi:10.1182/blood-2012-12-473413 · Cited by 128
Routy, J., Boulassel, M., Yassine‐Diab, B., Nicolette, C. A., Healey, D. G., Jain, R., Landry, C., Yegorov, O., Tcherepanova, I. Y., Monesmith, T., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.09.009 · Cited by 124
Salazar, A. Μ., Erlich, R. B., Mark, A. S., Bhardwaj, N., & Herberman, R. B. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0024 · Cited by 122
Self-citationHartung, E., Becker, M., Bachem, A., Reeg, N., Jaekel, A., Hutloff, A., Weber, H., Weise, C., Giesecke‐Thiel, C., Henn, V., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401903 · Cited by 121
Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma
Butterfield, L. H., Comin-Anduix, B., Vujanovic, L. N., Lee, Y., Dissette, V. B., Yang, J.-Q., Vu, H. T., Seja, E., Oseguera, D. K., Potter, D. M., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31816a8910 · Cited by 121
How vitamin A metabolizing dendritic cells are generated in the gut mucosa
Agace, W. W., & Persson, E. K. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.10.001 · Cited by 119
Targeting antigens to dendritic cells in vivo
Tacken, P. J., Torensma, R., & Figdor, C. G. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.021 · Cited by 118
Danger signals: a time and space continuum
Škoberne, M., Beignon, A., & Bhardwaj, N. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.04.001 · Cited by 118
Self-citationLui, G., Manches, O., Angel, J., Molens, J., Chaperot, L., & Plumas, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007111 · Cited by 117
CD54 is a surrogate marker of antigen presenting cell activation
Sheikh, N. A., & Jones, L. A. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0474-9 · Cited by 116
Ramakrishna, V., Treml, J., Vitale, L. A., Connolly, J. E., O’Neill, T. J., Smith, P. A., Jones, C. L., He, L.-Z., Goldstein, J., Wallace, P. K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2845 · Cited by 114
Krause, P., Bruckner, M., Uermösi, C., Singer, E., Groettrup, M., & Legler, D. F. (2008) · Blood · doi:10.1182/blood-2008-05-157123 · Cited by 114
Škoberne, M., Somersan, S., Almodovar, W., Truong, T., Petrova, K., Henson, P. M., & Bhardwaj, N. (2006) · Blood · doi:10.1182/blood-2005-12-4812 · Cited by 112
Self-citationMilazzo, C., Reichardt, V. L., Müller, M., Grünebach, F., & Brossart, P. (2003) · Blood · doi:10.1182/blood-2002-04-1273 · Cited by 111
Zhang, S., Kodys, K., Li, K., & Szabó, G. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.034 · Cited by 109
Bobadilla, S., Sunseri, N., & Landau, N. R. (2012) · Gene Therapy · doi:10.1038/gt.2012.61 · Cited by 106
Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy
Hatfield, P., Merrick, A. E., West, E. J., O’Donnell, D., Selby, P. J., Vile, R. G., & Melcher, A. A. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31818213df · Cited by 106
Lundberg, K., Albrekt, A.-S., Nelissen, I., Santegoets, S. J. A. M., de Gruijl, T. D., Gibbs, S., & Lindstedt, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052875 · Cited by 106
Anandasabapathy, N., Breton, G., Hurley, A., Caskey, M. F., Trumpfheller, C., Sarma, P., Pring, J., Pack, M., Buckley, N., Matei, I. R., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.74 · Cited by 105
Improving vaccines by targeting antigens to dendritic cells
Shortman, K., Lahoud, M. H., & Caminschi, I. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.2.008 · Cited by 104
Fossum, E., Grødeland, G., Terhorst‐Molawi, D., Tveita, A. A., Vikse, E. L., Mjaaland, S., Henri, S., MALISSEN, B., & Bogen, B. (2014) · European Journal of Immunology · doi:10.1002/eji.201445080 · Cited by 103
Dullaers, M., Meirvenne, S. V., Heirman, C., Straetman, L., Bonehill, A., Aerts, J. L., Thielemans, K., & Breckpot, K. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302697 · Cited by 102
Carrasco, J., Pel, A. V., Neyns, B., Lethé, B., Brasseur, F., Renkvist, N., van der Bruggen, P., van Baren, N., Paulus, R., Thielemans, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3585 · Cited by 99
Brentville, V. A., Metheringham, R. L., Gunn, B., Symonds, P., Daniels, I., Gijon, M., Cook, K., Xue, W., & Durrant, L. G. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1085 · Cited by 98
Wang, B., Zaidi, N., He, L.-Z., Zhang, L., Kuroiwa, J. M. Y., Keler, T., & Steinman, R. M. (2012) · Breast Cancer Research · doi:10.1186/bcr3135 · Cited by 97
Gerlini, G., Urso, C., Mariotti, G., Gennaro, P. D., Palli, D., Brandani, P., Salvadori, A., Pimpinelli, N., Reali, U. M., & Borgognoni, L. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.07.018 · Cited by 95
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
Vandenberk, L., Belmans, J., Woensel, M. V., Riva, M., & Gool, S. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00663 · Cited by 94
Li, J., Ahmet, F., Sullivan, L. C., Brööks, A. G., Kent, S. J., Rose, R. D., Salazar, A. Μ., Sousa, C. R. E., Shortman, K., Lahoud, M. H., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201445127 · Cited by 93
Schreibelt, G., Benítez‐Ribas, D., Schuurhuis, D. H., Lambeck, A. J. A., Hout-Kuijer, M. A. V., Schaft, N., Punt, C. J. A., Figdor, C. G., Adema, G. J., & de Vries, I. J. M. (2010) · Blood · doi:10.1182/blood-2009-11-251884 · Cited by 87
Redman, B. G., Chang, A. E., Whitfield, J. R., Esper, P., Jiang, G., Braun, T., Roessler, B. J., & Mulé, J. J. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31817fd90b · Cited by 87
Jinushi, M., Hodi, F. S., & Dranoff, G. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00618.x · Cited by 87
Pantel, A. R., Cheong, C., Dandamudi, D. B., Shrestha, E., Mehandru, S., Brane, L., Ruane, D., Teixeira, A., Bozzacco, L., Steinman, R. M., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141855 · Cited by 87
Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition
Tullett, K. M., Rojas, I. L., Minoda, Y., Tan, P. S., Zhang, J., Smith, C., Khanna, R., Shortman, K., Caminschi, I., Lahoud, M. H., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87102 · Cited by 86
The Dendritic Cell Synapse: A Life Dedicated to T Cell Activation
Benvenuti, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00070 · Cited by 84
Terhorst‐Molawi, D., Fossum, E., Barańska, A., Tamoutounour, S., Malosse, C., Garbani, M., Braun, R., Lechat, E., Crameri, R., Bogen, B., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500564 · Cited by 82
Romano, E., Rossi, M., Ratzinger, G., de Cos, M.-A., Chung, D. J., Panageas, K. S., Wolchock, J. D., Houghton, A. N., Chapman, P. B., Heller, G., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3421 · Cited by 82
Antigen loading of dendritic cells with whole tumor cell preparations
Thumann, P., Moc, I., Humrich, J. Y., Berger, T. G., Schultz, E. S., Schuler, G., & Jenne, L. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00102-9 · Cited by 81
Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall
Kato, Y., Zaid, A., Davey, G. M., Mueller, S. N., Nutt, S. L., Zotos, D., Tarlinton, D. M., Shortman, K., Lahoud, M. H., Heath, W. R., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500767 · Cited by 80
Genetic engineering of T cells for adoptive immunotherapy
Varela‐Rohena, A., Carpenito, C., Pérez, E., Richardson, M. W., Parry, R. V., Milone, M. C., Scholler, J., Hao, X., Mexas, A. M., Carroll, R. G., et al. (2008) · Immunologic Research · doi:10.1007/s12026-008-8057-6 · Cited by 80
Battaglia, A., Buzzonetti, A., Baranello, C., Ferrandina, G., Martinelli, E., Fanfani, F., Scambia, G., & Fattorossi, A. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0646-7 · Cited by 80
Müller, M., Tsakou, G., Grünebach, F., Schmidt, S. M., & Brossart, P. (2003) · Blood · doi:10.1182/blood-2003-06-2097 · Cited by 80
Lentivirus Vector-Mediated Expression of Tumor-Associated Epitopes by Human Antigen Presenting Cells
Lizee, G. A., Gonzales, M. I., & Topalian, S. L. (2004) · Human Gene Therapy · doi:10.1089/104303404322959542 · Cited by 75
Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily
Fox, J. C., Nakayama, T., Tyler, R. C., Sander, T. L., Yoshie, O., & Volkman, B. F. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.010 · Cited by 74
Barrou, B., Benoît, G., Ould-Kaci, M., Cussenot, O., Salcedo, M., Agrawal, S., Massicard, S., Bercovici, N., Ericson, M. L., & Thiounn, N. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0451-2 · Cited by 74
Defining human dendritic cell progenitors by multiparametric flow cytometry
Breton, G., Lee, J., Liu, K., & Nussenzweig, M. C. (2015) · Nature Protocols · doi:10.1038/nprot.2015.092 · Cited by 74
Suppressive Influences in the Immune Response to Cancer
Bronte, V., & D, S. M. M. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181837276 · Cited by 73
Krause, P., Singer, E., Darley, P. I., Klebensberger, J., Groettrup, M., & Legler, D. F. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905519 · Cited by 72
Apoptotic Cells at the Crossroads of Tolerance and Immunity
Škoberne, M., Beignon, A., Larsson, M., & Bhardwaj, N. (2005) · Springer eBooks · doi:10.1007/3-540-27320-4_12 · Cited by 71
Self-citationMarroquin, C. E., Westwood, J. A., Lapointe, R., Mixon, A., Wunderlich, J. R., Caron, D. A., Rosenberg, S. A., & Hwu, P. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200205000-00011 · Cited by 70
Bol, K. F., Aarntzen, E. H. J. G., Pots, J. M., Nordkamp, M. A. M. O., van de Rakt, M. W. M. M., Scharenborg, N. M., de Boer, A. J., van Oorschot, T. G. M., Croockewit, S., Blokx, W. A. M., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1796-7 · Cited by 70
Carpentier, S., Manh, T. V., Chelbi, R., Henri, S., MALISSEN, B., Haniffa, M. A., Ginhoux, F., & Dalod, M. (2016) · Journal of Immunological Methods · doi:10.1016/j.jim.2016.02.023 · Cited by 66
Dendritic cells under the spell of prostaglandins
Morelli, A. E., & Thomson, A. W. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00023-1 · Cited by 65
CRISPR/Cas9 and cancer targets: future possibilities and present challenges
White, M. K., & Khalili, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7104 · Cited by 65
Veron, P., Allo, V., Rivière, C., Bernard, J., Douar, A. M., & Masurier, C. (2007) · Journal of Virology · doi:10.1128/jvi.02516-06 · Cited by 64
Zeestraten, E. C. M., Speetjens, F. M., Welters, M. J. P., Saadatmand, S., Stynenbosch, L. F. M., Jongen, R., Kapiteijn, E., Gelderblom, H. A. J., Nijman, H. W., Valentijn, A. R. P. M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27819 · Cited by 64
Cited by
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470
Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 592
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Immune Cell Membrane‐Coated Biomimetic Nanoparticles for Targeted Cancer Therapy
Oroojalian, F., Beygi, M., Baradaran, B., Mokhtarzadeh, A., & Shahbazi, M. (2021) · Small · doi:10.1002/smll.202006484 · Cited by 528
Picard, E., Verschoor, C. P., Ma, G. W., & Pawelec, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00369 · Cited by 522
Metadata
- Authors
- Sabado, R. L., Balan, S., & Bhardwaj, N.
- Venue
- Cell Research
- Published
- 2016-12-27
- Volume
- 27
- Issue
- 1
- Pages
- 74-95
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2561499686
- Cited by
- 927
- References
- 228
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.